Additional Resources
These sites can help you learn more about COPD and how to manage it:
Note: The Web sites below are external to GlaxoSmithKline. GlaxoSmithKline does not possess editorial control over the content of the information provided in the Web sites below, and therefore, does not warrant their accuracy and completeness.
American Association for Respiratory Care
www.yourlunghealth.org
American College of Chest Physicians (patient education guides)
http://www.chestnet.org/patients/guides
American Lung Association
www.lungusa.org
The American Thoracic Society
www.thoracic.org
COPD – ALERT Support and Advocacy Group
www.copd-alert.com
The COPD Foundation
www.copdfoundation.org
The Global Initiative for Chronic Obstructive Lung Disease
www.goldcopd.com
National Emphysema/COPD Association (NECA)
www.NECAcommunity.org
National Family Caregiver Support Program
http://www.aoa.gov/prof/aoaprog/caregiver/caregiver.aspx
National Heart Lung and Blood Institute
www.nhlbi.nih.gov
National Home Oxygen Patients Association (NHOPA)
www.homeoxygen.org
National Lung Health Education Program
www.nlhep.org
Pulmonary Education and Research Foundation (PERF)
www.perf2ndwind.org
SPRY (Setting Priorities for Retirement Years) Foundation
www.spry.org
Important Safety Information About ADVAIR DISKUS 250/50
ADVAIR DISKUS 250/50 is approved for adults with COPD, including chronic bronchitis, emphysema, or both. You should only take 1 inhalation of ADVAIR twice a day. Higher doses will not provide additional benefits. People with COPD taking ADVAIR may have a higher chance of pneumonia. Call your doctor if you notice any of the following symptoms: change in amount or color of sputum, fever, chills, increased cough, or increased breathing problems.
ADVAIR may increase your risk of osteoporosis and some eye problems (cataracts or glaucoma). You should have regular eye exams. Thrush in the mouth and throat may occur. Tell your doctor if you have a heart condition or high blood pressure before taking ADVAIR. Do not use ADVAIR with long-acting beta2-agonists for any reason. ADVAIR does not replace fast-acting inhalers for sudden symptoms.